Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno–oncology portfolio. [...] Read more »